Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | International

Kanada. How Canadian Drug Users Helped Save an Injectable Opioid Agonist Program

Kanada. How Canadian Drug Users Helped Save an Injectable Opioid Agonist Program

Amid a historic fatal overdose crisis, the Canadian province of Alberta wanted to end an opioid use disorder (OUD) treatment program that met the needs of patients for whom oral opioid agonist treatment (oOAT), like methadone or buprenorphine, had proven unsuccessful.

But a group of 11 patients enrolled in the government-funded injectable opioid agonist treatment (iOAT) clinics—based in Edmonton and Calgary, and providing supervised hydromorphone injections alongside wrap-around social services—were not going to let their program go down without a fight. (Filter, USA, 03.03.2021)

https://filtermag.org/alberta-injectable-opioid-agonist-treatment/amp/